Evidence map›Paper›PMID 38496321›Full record

ArticleToxicology research2024

Hexaconazole exposure may lead to Parkinson via disrupting glucocerebrosidase and parkin: molecular interaction, dynamics, MMPBSA and DFT based

Faisal K Alkholifi, Sayed Aliul Hasan Abdi, Marwa Qadri, Shabihul Fatma Sayed, Amani Khardali, Sumathi Nagarajan, Alhamyani Abdulrahman, Nayef Aldabaan, Yahia Alghazwani

Open access · greenAbstract read
In one paragraph

Article in Toxicology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Faisal K AlkholifiDepartment of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Abdullah bin Amer Street, Riyadh region, Al-Kharj 16278, Saudi Arabia.ORCID https://orcid.org/0000-0003-3150-3439
Sayed Aliul Hasan AbdiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Baha University, Al-Baha 65779, Saudi Arabia.ORCID https://orcid.org/0000-0002-3339-3264
Marwa QadriDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Shabihul Fatma SayedDepartment of Nursing, Farasan University College, Jazan University, 54943, Saudi Arabia.ORCID https://orcid.org/0000-0003-0115-9446
Amani KhardaliDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142 Saudi Arabia.ORCID https://orcid.org/0000-0002-5611-4782
Sumathi NagarajanDepartment of Nursing, Farasan University College, Jazan University, 54943, Saudi Arabia.
Alhamyani AbdulrahmanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Baha University, Al-Baha 65779, Saudi Arabia.ORCID https://orcid.org/0009-0003-2346-7631
Nayef AldabaanDepartment of Pharmacology, College of Pharmacy, Najran University, Najran 61441, Saudi Arabia.
Yahia AlghazwaniDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
Al Baha University · SAJazan University · SASaudi Electronic University · SAKing Khalid University · SANajran University · SAPrince Sattam Bin Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hexaconazole is a known fungicide for agricultural purposes. It has bioaccumulation ability which makes it important for its toxicological characterization. There are various neurological impacts of pollutants on human health. Therefore, in this study, we have done predictive analyses of the interaction mechanism of hexaconazole by molecular interaction analysis, molecular dynamics simulation, and Poisson-Boltzmann surface area (MM-PBSA) to assess hexaconazole's potency to disrupt the homeostasis of glucocerebrosidase (-7.9 kcal/mol) and parkin (-5.67 kcal/mol) proteins which have significant roles in the manifestation of Parkinson disease. The findings reveal that hexaconazole has the potency to form stable interactions with glucocerebrosidase and parkin. This research provides a molecular and atomic-level understanding of how hexaconazole exposure may disrupt the homeostasis of glucocerebrosidase and parkin. The root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration, and hydrogen bonding exhibited the potent molecular interactions of hexaconazole, which may lead to neurological manifestations such as Parkinson disease.

Indexed as

agricultural fungicidecomputation toxicologyenvironmental exposureglucocerebrosidasehexaconazoleparkin

Identifiers

PMID38496321
PMCPMC10939372
OpenAlexW4391892718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.